Trademark: 97229623
Word
THE RNA PRINTER
Status
Registered
Status Code
700
Status Date
Tuesday, January 23, 2024
Serial Number
97229623
Registration Number
7289725
Registration Date
Tuesday, January 23, 2024
Mark Type
4000
Filing Date
Thursday, January 20, 2022

Trademark Owner History
CureVac RNA Printer GmbH - Original Registrant

Classifications
9 (Based on 44(d) Priority Application) Apparatus for chemical synthesis; mobile laboratory; mobile device for the synthesis of macromolecules
5 (Based on 44(e)) Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovacular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; Pharmaceutical and veterinary preparations; Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment of infectious diseases, allergies, autoimmune disorder and tumour diseases, for treatment of metabolic disorders and for treatment of inherited genetic disease or for protein or enzyme replacement therapy; Gene therapeutic preparations, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Health care products, namely, bacterioligical, or bacterial, or vitamin, or sanitary preparations for medical use; Dietetic substances adapted for medical use, in particular substances for food supplements
1 (Based on 44(e)) Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
44 (Based on 44(e)) Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
42 (Based on 44(e)) Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical scientific testing of macromolecules
"RNA"

Trademark Events
Jan 23, 2024
Notice Of Registration Confirmation Emailed
Jan 23, 2024
Registered-Supplemental Register
Oct 18, 2023
Approved For Registration Supplemental Register
Sep 27, 2023
Teas/Email Correspondence Entered
Sep 27, 2023
Correspondence Received In Law Office
Sep 27, 2023
Assigned To Lie
May 8, 2023
Teas Response To Office Action Received
Nov 8, 2022
Notification Of Non-Final Action E-Mailed
Nov 8, 2022
Non-Final Action E-Mailed
Nov 8, 2022
Non-Final Action Written
Oct 30, 2022
Assigned To Examiner
Jan 25, 2022
New Application Office Supplied Data Entered
Jan 24, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24